Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 61 entries
Sorted by: Best Match Show Resources per page
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.

PLoS medicine

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.
PMID: 26030872
PLoS Med. 2015 Jun 01;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun.

No abstract available.

Cite
Rhee SY, Blanco JL, Jordan MR, et al. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. PLoS Med. 2015;12(6):e1001845doi: 10.1371/journal.pmed.1001845.
Rhee, S. Y., Blanco, J. L., Jordan, M. R., Taylor, J., Lemey, P., Varghese, V., Hamers, R. L., Bertagnolio, S., de Wit, T. F., Aghokeng, A. F., Albert, J., Avi, R., Avila-Rios, S., Bessong, P. O., Brooks, J. I., Boucher, C. A., Brumme, Z. L., Busch, M. P., Bussmann, H., Chaix, M. L., Chin, B. S., D'Aquin, T. T., De Gascun, C. F., Derache, A., Descamps, D., Deshpande, A. K., Djoko, C. F., Eshleman, S. H., Fleury, H., Frange, P., Fujisaki, S., Harrigan, P. R., Hattori, J., Holguin, A., Hunt, G. M., Ichimura, H., Kaleebu, P., Katzenstein, D., Kiertiburanakul, S., Kim, J. H., Kim, S. S., Li, Y., Lutsar, I., Morris, L., Ndembi, N., Kee, P. N., Paranjape, R. S., Peeters, M., Poljak, M., Price, M. A., Ragonnet-Cronin, M. L., Reyes-Terán, G., Rolland, M., Sirivichayakul, S., Smith, D. M., Soares, M. A., Soriano, V. V., Ssemwanga, D., Stanojevic, M., Stefani, M. A., Sugiura, W., Sungkanuparph, S., Tanuri, A., Tee, K. K., Truong, H. M., van de Vijver, D. A., Vidal, N., Yang, C., Yang, R., Yebra, G., Ioannidis, J. P., Vandamme, A. M., & Shafer, R. W. (2015). Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. PLoS medicine, 12(6), e1001845. https://doi.org/10.1371/journal.pmed.1001845
Rhee, Soo-Yon, et al. "Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis." PLoS medicine vol. 12,6 (2015): e1001845. doi: https://doi.org/10.1371/journal.pmed.1001845
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. PLoS Med. 2015 Jun 01;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun. PMID: 26030872; PMCID: PMC4452696.
Copy Download .nbib Format: NLM
Prevention of the sexual transmission of HIV-1: preparing for success.

Journal of the International AIDS Society

Cohen MS, Kaleebu P, Coates T.
PMID: 19014659
J Int AIDS Soc. 2008 Oct 01;11:4. doi: 10.1186/1758-2652-11-4.

There are four opportunities for HIV prevention: before exposure, at the moment of exposure, immediately after exposure, and as secondary prevention focused on infected subjects. Until recently, most resources have been directed toward behavioral strategies aimed at preventing exposure...

Cite
Cohen MS, Kaleebu P, Coates T. Prevention of the sexual transmission of HIV-1: preparing for success. J Int AIDS Soc. 2008;11:4doi: 10.1186/1758-2652-11-4.
Cohen, M. S., Kaleebu, P., & Coates, T. (2008). Prevention of the sexual transmission of HIV-1: preparing for success. Journal of the International AIDS Society, 114. https://doi.org/10.1186/1758-2652-11-4
Cohen, Myron S, et al. "Prevention of the sexual transmission of HIV-1: preparing for success." Journal of the International AIDS Society vol. 11 (2008): 4. doi: https://doi.org/10.1186/1758-2652-11-4
Cohen MS, Kaleebu P, Coates T. Prevention of the sexual transmission of HIV-1: preparing for success. J Int AIDS Soc. 2008 Oct 01;11:4. doi: 10.1186/1758-2652-11-4. PMID: 19014659; PMCID: PMC2584059.
Copy Download .nbib Format: NLM
Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008.

Population health metrics

Mayanja BN, Baisley K, Nalweyiso N, Kibengo FM, Mugisha JO, Van der Paal L, Maher D, Kaleebu P.
PMID: 21816100
Popul Health Metr. 2011 Aug 04;9:36. doi: 10.1186/1478-7954-9-36.

BACKGROUND: Verbal autopsy is important for detecting causes of death including HIV in areas with inadequate vital registration systems. Before antiretroviral therapy (ART) introduction, a verbal autopsy study in rural Uganda found that half of adult deaths assessed were...

Cite
Mayanja BN, Baisley K, Nalweyiso N, et al. Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008. Popul Health Metr. 2011;9:36doi: 10.1186/1478-7954-9-36.
Mayanja, B. N., Baisley, K., Nalweyiso, N., Kibengo, F. M., Mugisha, J. O., Van der Paal, L., Maher, D., & Kaleebu, P. (2011). Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008. Population health metrics, 936. https://doi.org/10.1186/1478-7954-9-36
Mayanja, Billy N, et al. "Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008." Population health metrics vol. 9 (2011): 36. doi: https://doi.org/10.1186/1478-7954-9-36
Mayanja BN, Baisley K, Nalweyiso N, Kibengo FM, Mugisha JO, Van der Paal L, Maher D, Kaleebu P. Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008. Popul Health Metr. 2011 Aug 04;9:36. doi: 10.1186/1478-7954-9-36. PMID: 21816100; PMCID: PMC3160929.
Copy Download .nbib Format: NLM
Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.

Current infectious disease reports

Saleeb P, Olivier KN.
PMID: 21308530
Curr Infect Dis Rep. 2010 May;12(3):198-203. doi: 10.1007/s11908-010-0103-6.

Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and cause a wide range of diseases in humans. Pulmonary involvement, the most common disease manifestation of NTM infection, is being increasingly encountered in clinical settings. In addition, specific phenotypic and...

Cite
Saleeb P, Olivier KN. Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Curr Infect Dis Rep. 2010;12(3):198-203doi: 10.1007/s11908-010-0103-6.
Saleeb, P., & Olivier, K. N. (2010). Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Current infectious disease reports, 12(3), 198-203. https://doi.org/10.1007/s11908-010-0103-6
Saleeb, Paul, and Olivier, Kenneth N. "Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients." Current infectious disease reports vol. 12,3 (2010): 198-203. doi: https://doi.org/10.1007/s11908-010-0103-6
Saleeb P, Olivier KN. Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Curr Infect Dis Rep. 2010 May;12(3):198-203. doi: 10.1007/s11908-010-0103-6. PMID: 21308530; PMCID: PMC3058739.
Copy Download .nbib Format: NLM
HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa.

Global health, epidemiology and genomics

Ekoru K, Young EH, Dillon DG, Gurdasani D, Stehouwer N, Faurholt-Jepsen D, Levitt NS, Crowther NJ, Nyirenda M, Njelekela MA, Ramaiya K, Nyan O, Adewole OO, Anastos K, Compostella C, Dave JA, Fourie CM, Friis H, Kruger IM, Longenecker CT, Maher DP, Mutimura E, Ndhlovu CE, Praygod G, Pefura Yone EW, Pujades-Rodriguez M, Range N, Sani MU, Sanusi M, Schutte AE, Sliwa K, Tien PC, Vorster EH, Walsh C, Gareta D, Mashili F, Sobngwi E, Adebamowo C, Kamali A, Seeley J, Smeeth L, Pillay D, Motala AA, Kaleebu P, Sandhu MS.
PMID: 29881632
Glob Health Epidemiol Genom. 2018;3. doi: 10.1017/gheg.2018.7. Epub 2018 May 08.

BACKGROUND: Anti-retroviral therapy (ART) regimes for HIV are associated with raised levels of circulating triglycerides (TG) in western populations. However, there are limited data on the impact of ART on cardiometabolic risk in sub-Saharan African (SSA) populations.METHODS: Pooled analyses...

Cite
Ekoru K, Young EH, Dillon DG, et al. HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa. Glob Health Epidemiol Genom. 2018;3doi: 10.1017/gheg.2018.7.
Ekoru, K., Young, E. H., Dillon, D. G., Gurdasani, D., Stehouwer, N., Faurholt-Jepsen, D., Levitt, N. S., Crowther, N. J., Nyirenda, M., Njelekela, M. A., Ramaiya, K., Nyan, O., Adewole, O. O., Anastos, K., Compostella, C., Dave, J. A., Fourie, C. M., Friis, H., Kruger, I. M., Longenecker, C. T., Maher, D. P., Mutimura, E., Ndhlovu, C. E., Praygod, G., Pefura Yone, E. W., Pujades-Rodriguez, M., Range, N., Sani, M. U., Sanusi, M., Schutte, A. E., Sliwa, K., Tien, P. C., Vorster, E. H., Walsh, C., Gareta, D., Mashili, F., Sobngwi, E., Adebamowo, C., Kamali, A., Seeley, J., Smeeth, L., Pillay, D., Motala, A. A., Kaleebu, P., & Sandhu, M. S. (2018). HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa. Global health, epidemiology and genomics, 3. https://doi.org/10.1017/gheg.2018.7
Ekoru, Kenneth, et al. "HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa." Global health, epidemiology and genomics vol. 3 (2018). doi: https://doi.org/10.1017/gheg.2018.7
Ekoru K, Young EH, Dillon DG, Gurdasani D, Stehouwer N, Faurholt-Jepsen D, Levitt NS, Crowther NJ, Nyirenda M, Njelekela MA, Ramaiya K, Nyan O, Adewole OO, Anastos K, Compostella C, Dave JA, Fourie CM, Friis H, Kruger IM, Longenecker CT, Maher DP, Mutimura E, Ndhlovu CE, Praygod G, Pefura Yone EW, Pujades-Rodriguez M, Range N, Sani MU, Sanusi M, Schutte AE, Sliwa K, Tien PC, Vorster EH, Walsh C, Gareta D, Mashili F, Sobngwi E, Adebamowo C, Kamali A, Seeley J, Smeeth L, Pillay D, Motala AA, Kaleebu P, Sandhu MS. HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa. Glob Health Epidemiol Genom. 2018;3. doi: 10.1017/gheg.2018.7. Epub 2018 May 08. PMID: 29881632; PMCID: PMC5985947.
Copy Download .nbib Format: NLM
Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda.

AIDS research and human retroviruses

Galiwango RM, Ssuuna C, Kaleebu P, Kigozi G, Kagaayi J, Nakigozi G, Reynolds SJ, Lutalo T, Kankaka EN, Wasswa JB, Kalibbala SN, Kigozi AN, Watera C, Ejang J, Ndyanabo A, Anok AJ, Ssemwanga D, Kibengo FM, Quinn TC, Grabowski M, Chang LW, Wawer M, Gray R, Laeyendecker O, Serwadda D.
PMID: 33499732
AIDS Res Hum Retroviruses. 2021 Feb 25; doi: 10.1089/AID.2020.0279. Epub 2021 Feb 25.

Point of care rapid recency testing for HIV-1 may be a cost-effective tool to identify recently infected individuals for incidence estimation, and focused HIV prevention through intensified contact tracing. We validated the Asante™ HIV-1 rapid recency

Cite
Galiwango RM, Ssuuna C, Kaleebu P, et al. Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda. AIDS Res Hum Retroviruses. 2021;doi: 10.1089/AID.2020.0279.
Galiwango, R. M., Ssuuna, C., Kaleebu, P., Kigozi, G., Kagaayi, J., Nakigozi, G., Reynolds, S. J., Lutalo, T., Kankaka, E. N., Wasswa, J. B., Kalibbala, S. N., Kigozi, A. N., Watera, C., Ejang, J., Ndyanabo, A., Anok, A. J., Ssemwanga, D., Kibengo, F. M., Quinn, T. C., Grabowski, M., Chang, L. W., Wawer, M., Gray, R., Laeyendecker, O., & Serwadda, D. (2021). Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda. AIDS research and human retroviruses, . https://doi.org/10.1089/AID.2020.0279
Galiwango, Ronald Moses, et al. "Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda." AIDS research and human retroviruses vol. (2021). doi: https://doi.org/10.1089/AID.2020.0279
Galiwango RM, Ssuuna C, Kaleebu P, Kigozi G, Kagaayi J, Nakigozi G, Reynolds SJ, Lutalo T, Kankaka EN, Wasswa JB, Kalibbala SN, Kigozi AN, Watera C, Ejang J, Ndyanabo A, Anok AJ, Ssemwanga D, Kibengo FM, Quinn TC, Grabowski M, Chang LW, Wawer M, Gray R, Laeyendecker O, Serwadda D. Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda. AIDS Res Hum Retroviruses. 2021 Feb 25; doi: 10.1089/AID.2020.0279. Epub 2021 Feb 25. PMID: 33499732.
Copy Download .nbib Format: NLM
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A.
PMID: 34863925
Int J Infect Dis. 2022 Jan;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 01.

No abstract available.

Cite
Petersen E, Ntoumi F, Hui DS, et al. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2021;114:268-272doi: 10.1016/j.ijid.2021.11.040.
Petersen, E., Ntoumi, F., Hui, D. S., Abubakar, A., Kramer, L. D., Obiero, C., Tambyah, P. A., Blumberg, L., Yapi, R., Al-Abri, S., Pinto, T. C. A., Yeboah-Manu, D., Haider, N., Asogun, D., Velavan, T. P., Kapata, N., Bates, M., Ansumana, R., Montaldo, C., Mucheleng'anga, L., Tembo, J., Mwaba, P., Himwaze, C. M., Hamid, M. M. A., Mfinanga, S., Mboera, L., Raj, T., Aklillu, E., Veas, F., Edwards, S., Kaleebu, P., McHugh, T. D., Chakaya, J., Nyirenda, T., Bockarie, M., Nyasulu, P. S., Wejse, C., Muyembe-Tamfum, J. J., Azhar, E. I., Maeurer, M., Nachega, J. B., Kock, R., Ippolito, G., & Zumla, A. (2022). Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 114268-272. https://doi.org/10.1016/j.ijid.2021.11.040
Petersen, Eskild, et al. "Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 114 (2022): 268-272. doi: https://doi.org/10.1016/j.ijid.2021.11.040
Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2022 Jan;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 01. PMID: 34863925; PMCID: PMC8634699.
Copy Download .nbib Format: NLM
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A.
PMID: 34863925
Int J Infect Dis. 2021 Dec 01;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 01.

No abstract available.

Cite
Petersen E, Ntoumi F, Hui DS, et al. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2021;114:268-272doi: 10.1016/j.ijid.2021.11.040.
Petersen, E., Ntoumi, F., Hui, D. S., Abubakar, A., Kramer, L. D., Obiero, C., Tambyah, P. A., Blumberg, L., Yapi, R., Al-Abri, S., Pinto, T. C. A., Yeboah-Manu, D., Haider, N., Asogun, D., Velavan, T. P., Kapata, N., Bates, M., Ansumana, R., Montaldo, C., Mucheleng'anga, L., Tembo, J., Mwaba, P., Himwaze, C. M., Hamid, M. M. A., Mfinanga, S., Mboera, L., Raj, T., Aklillu, E., Veas, F., Edwards, S., Kaleebu, P., McHugh, T. D., Chakaya, J., Nyirenda, T., Bockarie, M., Nyasulu, P. S., Wejse, C., Muyembe-Tamfum, J. J., Azhar, E. I., Maeurer, M., Nachega, J. B., Kock, R., Ippolito, G., & Zumla, A. (2021). Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 114268-272. https://doi.org/10.1016/j.ijid.2021.11.040
Petersen, Eskild, et al. "Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 114 (2021): 268-272. doi: https://doi.org/10.1016/j.ijid.2021.11.040
Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2021 Dec 01;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 01. PMID: 34863925; PMCID: PMC8634699.
Copy Download .nbib Format: NLM
Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda.

Medicine

Kusemererwa S, Kansiime S, Mutonyi G, Namirembe A, Katana S, Kitonsa J, Kakande A, Okello JM, Kaleebu P, Ruzagira E, Sein MK, Thapa D, Hatakka M.
PMID: 34871265
Medicine (Baltimore). 2021 Nov 05;100(44):e27719. doi: 10.1097/MD.0000000000027719.

ABSTRACT: Oral pre-exposure prophylaxis (PrEP) significantly reduces human immunodeficiency virus (HIV) acquisition risk. However, data on predictors of PrEP uptake in sub-Saharan Africa are limited. We assessed predictors of PrEP uptake among HIV-uninfected high risk individuals enrolled in a...

Cite
Kusemererwa S, Kansiime S, Mutonyi G, et al. Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda. Medicine (Baltimore). 2021;100(44):e27719doi: 10.1097/MD.0000000000027719.
Kusemererwa, S., Kansiime, S., Mutonyi, G., Namirembe, A., Katana, S., Kitonsa, J., Kakande, A., Okello, J. M., Kaleebu, P., Ruzagira, E., Sein, M. K., Thapa, D., & Hatakka, M. (2021). Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda. Medicine, 100(44), e27719. https://doi.org/10.1097/MD.0000000000027719
Kusemererwa, Sylvia, et al. "Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda." Medicine vol. 100,44 (2021): e27719. doi: https://doi.org/10.1097/MD.0000000000027719
Kusemererwa S, Kansiime S, Mutonyi G, Namirembe A, Katana S, Kitonsa J, Kakande A, Okello JM, Kaleebu P, Ruzagira E, Sein MK, Thapa D, Hatakka M. Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda. Medicine (Baltimore). 2021 Nov 05;100(44):e27719. doi: 10.1097/MD.0000000000027719. PMID: 34871265; PMCID: PMC8568469.
Copy Download .nbib Format: NLM
HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021.

AIDS research and human retroviruses

Laher F, Richardson SI, Smith P, Sullivan PS, Abrahams AG, Asowata OE, Bitangumutwenzi P, Dabee S, Dollah A, Fernandez N, Langat RK, Bose DL, Likhitwonnawut U, Mullick R, Resop RS, Sutar J, Thompson-Hall AN, Traeger MW, Tuyishime M, Wambui J, Bekker LG, Kaleebu P, McCormack S, O'Connor DH, Warren M, Torri T, Thyagarajan B.
PMID: 34714100
AIDS Res Hum Retroviruses. 2021 Nov 25; doi: 10.1089/AID.2021.0138. Epub 2021 Nov 25.

The HIV Research for Prevention (HIVR4P) conference catalyzes knowledge sharing on biomedical HIV prevention interventions such as HIV vaccines, antibody infusions, pre-exposure prophylaxis, and microbicides in totality-from the molecular details and delivery formulations to the behavioral, social, and structural...

Cite
Laher F, Richardson SI, Smith P, et al. HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021. AIDS Res Hum Retroviruses. 2021;doi: 10.1089/AID.2021.0138.
Laher, F., Richardson, S. I., Smith, P., Sullivan, P. S., Abrahams, A. G., Asowata, O. E., Bitangumutwenzi, P., Dabee, S., Dollah, A., Fernandez, N., Langat, R. K., Bose, D. L., Likhitwonnawut, U., Mullick, R., Resop, R. S., Sutar, J., Thompson-Hall, A. N., Traeger, M. W., Tuyishime, M., Wambui, J., Bekker, L. G., Kaleebu, P., McCormack, S., O'Connor, D. H., Warren, M., Torri, T., & Thyagarajan, B. (2021). HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021. AIDS research and human retroviruses, . https://doi.org/10.1089/AID.2021.0138
Laher, Fatima, et al. "HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021." AIDS research and human retroviruses vol. (2021). doi: https://doi.org/10.1089/AID.2021.0138
Laher F, Richardson SI, Smith P, Sullivan PS, Abrahams AG, Asowata OE, Bitangumutwenzi P, Dabee S, Dollah A, Fernandez N, Langat RK, Bose DL, Likhitwonnawut U, Mullick R, Resop RS, Sutar J, Thompson-Hall AN, Traeger MW, Tuyishime M, Wambui J, Bekker LG, Kaleebu P, McCormack S, O'Connor DH, Warren M, Torri T, Thyagarajan B. HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021. AIDS Res Hum Retroviruses. 2021 Nov 25; doi: 10.1089/AID.2021.0138. Epub 2021 Nov 25. PMID: 34714100.
Copy Download .nbib Format: NLM
Risk assessment for the implementation of controlled human .

AAS open research

Koopman JP, Egesa M, Wajja A, Adriko M, Nassuuna J, Nkurunungi G, Driciru E, van Willigen G, Cose S, Yazdanbakhsh M, Kaleebu P, Kabatereine N, Tukahebwa E, Roestenberg M, Elliott AM.
PMID: 31819922
AAS Open Res. 2019 Aug 13;2:17. doi: 10.12688/aasopenres.12972.2. eCollection 2019.

Schistosomiasis is a parasitic infection highly prevalent in sub-Saharan Africa, and a significant cause of morbidity; it is a priority for vaccine development. A controlled human infection model for

Cite
Koopman JP, Egesa M, Wajja A, et al. Risk assessment for the implementation of controlled human . AAS Open Res. 2019;2:17doi: 10.12688/aasopenres.12972.2.
Koopman, J. P., Egesa, M., Wajja, A., Adriko, M., Nassuuna, J., Nkurunungi, G., Driciru, E., van Willigen, G., Cose, S., Yazdanbakhsh, M., Kaleebu, P., Kabatereine, N., Tukahebwa, E., Roestenberg, M., & Elliott, A. M. (2019). Risk assessment for the implementation of controlled human . AAS open research, 217. https://doi.org/10.12688/aasopenres.12972.2
Koopman, Jan Pieter, et al. "Risk assessment for the implementation of controlled human ." AAS open research vol. 2 (2019): 17. doi: https://doi.org/10.12688/aasopenres.12972.2
Koopman JP, Egesa M, Wajja A, Adriko M, Nassuuna J, Nkurunungi G, Driciru E, van Willigen G, Cose S, Yazdanbakhsh M, Kaleebu P, Kabatereine N, Tukahebwa E, Roestenberg M, Elliott AM. Risk assessment for the implementation of controlled human . AAS Open Res. 2019 Aug 13;2:17. doi: 10.12688/aasopenres.12972.2. eCollection 2019. PMID: 31819922; PMCID: PMC6901351.
Copy Download .nbib Format: NLM
Alternate primers for whole-genome SARS-CoV-2 sequencing.

Virus evolution

Cotten M, Lule Bugembe D, Kaleebu P, V T Phan M.
PMID: 33841912
Virus Evol. 2021 Feb 04;7(1):veab006. doi: 10.1093/ve/veab006. eCollection 2021 Jan.

As the world is struggling to control the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), there is an urgency to develop effective control measures. Essential information is encoded in the virus genome sequence with accurate and complete SARS-CoV-2...

Cite
Cotten M, Lule Bugembe D, Kaleebu P, et al. Alternate primers for whole-genome SARS-CoV-2 sequencing. Virus Evol. 2021;7(1):veab006doi: 10.1093/ve/veab006.
Cotten, M., Lule Bugembe, D., Kaleebu, P., & V T Phan, M. (2021). Alternate primers for whole-genome SARS-CoV-2 sequencing. Virus evolution, 7(1), veab006. https://doi.org/10.1093/ve/veab006
Cotten, Matthew, et al. "Alternate primers for whole-genome SARS-CoV-2 sequencing." Virus evolution vol. 7,1 (2021): veab006. doi: https://doi.org/10.1093/ve/veab006
Cotten M, Lule Bugembe D, Kaleebu P, V T Phan M. Alternate primers for whole-genome SARS-CoV-2 sequencing. Virus Evol. 2021 Feb 04;7(1):veab006. doi: 10.1093/ve/veab006. eCollection 2021 Jan. PMID: 33841912; PMCID: PMC7928614.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 61 entries